Sustained Regression of Hydroxycarbamide Induced Actinic Keratoses after Switching to Anagrelide

Hydroxycarbamide (HC) is the first-line treatment for certain myeloproliferative neoplasms, such as polycythemia vera and essential thrombocytosis (ET). In a subset of these patients long-term treatment with HC can result in the development of confluent actinic keratoses (AK) followed by invasive ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaitanis, Georgios, Gougopoulou, Dora, Kapsali, Eleni, Bassukas, Ioannis D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892259/
https://www.ncbi.nlm.nih.gov/pubmed/29780645
http://dx.doi.org/10.1155/2018/2874012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892259/
https://www.ncbi.nlm.nih.gov/pubmed/29780645
http://dx.doi.org/10.1155/2018/2874012

Ejemplares similares